This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

Christopher Cheng, PhD
Vice President, Process Development & Tech Transfer at Verve Therapeutics
Speaker

Agenda Sessions

  • Verve's in vivo Base Editor CMC Development Path: Optimization, Scale-up, and Continuous Improvement

    , 11:45am
    View Session

At this event

Prev
Next
Adam Oxley, PhD
Deputy Vice President of Membranes and Purification
Exactmer

See Christopher at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now